NasdaqGS:OFIXMedical Equipment
Orthofix Medical (OFIX) Loss Narrows Sharply In Q4 Challenging Bearish Earnings Narrative
Orthofix Medical (OFIX) has just posted its FY 2025 fourth quarter scorecard, reporting revenue of US$219.9 million and a basic EPS loss of US$0.06. Trailing 12 month revenue stands at US$822.3 million against a net loss of US$92.2 million. Over the past few quarters, the company has reported revenue increasing from US$193.6 million in Q1 2025 to US$219.9 million in Q4 2025, while basic EPS losses narrowed from US$1.35 to US$0.06. This outlines an earnings story that remains marked by...